1. Home
  2. WAFDP vs HUMAW Comparison

WAFDP vs HUMAW Comparison

Compare WAFDP & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WaFd Inc. Depositary Shares

WAFDP

WaFd Inc. Depositary Shares

N/A

Current Price

$17.10

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

N/A

Current Price

$0.09

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WAFDP
HUMAW
Founded
N/A
2004
Country
United States
United States
Employees
2208
220
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WAFDP
HUMAW
Price
$17.10
$0.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
14.2K
Earning Date
N/A
03-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$1.18
52 Week High
N/A
$1.34

Technical Indicators

Market Signals
Indicator
WAFDP
HUMAW
Relative Strength Index (RSI) 66.27 34.18
Support Level $16.90 $0.09
Resistance Level $17.15 $0.13
Average True Range (ATR) 0.20 0.03
MACD 0.01 -0.00
Stochastic Oscillator 86.30 4.14

Price Performance

Historical Comparison
WAFDP
HUMAW

About WAFDP WaFd Inc. Depositary Shares

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: